Risk factors for hospital readmission in adult patients with heart failure with reduced ejection fraction: a systematic review

被引:6
作者
Schjodt, Inge [1 ]
Liljeroos, Maria [2 ,3 ]
Larsen, Palle [4 ]
Johnsen, Soren Paaske [5 ]
Stromberg, Anna [2 ,6 ]
Logstrup, Brian Bridal [1 ,7 ]
机构
[1] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark
[2] Linkoping Univ, Dept Hlth Med & Caring Sci, Linkoping, Sweden
[3] Uppsala Univ, Ctr Clin Res Sormland, Eskilstuna, Sweden
[4] Univ Coll Lillebaelt, Hlth Sci Res Ctr, Odense, Denmark
[5] Aalborg Univ, Dept Clin Med, Danish Ctr Clin Hlth Serv Res, Aalborg, Denmark
[6] Linkoping Univ Hosp, Dept Cardiol, Linkoping, Sweden
[7] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
关键词
all-cause readmission; heart failure; heart failure readmission; rehospitalization; risk factors; ASSOCIATION TASK-FORCE; BETA-BLOCKER USE; SYSTOLIC BLOOD-PRESSURE; TERM CLINICAL-OUTCOMES; ADMISSION SERUM SODIUM; 30-DAY READMISSION; AMERICAN-COLLEGE; ANTICOAGULATION THERAPY; PROGNOSTIC-SIGNIFICANCE; PERFORMANCE-MEASURES;
D O I
10.11124/JBISRIR-D-19-00203
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective:The objective of this review was to identify and synthesize evidence on risk factors associated with hospital readmission within the first year after heart failure hospitalization among patients with heart failure with reduced left ventricular ejection fraction.Introduction:Heart failure is associated with a high risk of hospital readmission. Readmissions are associated with higher mortality and health care costs. It is a high health care priority to identify vulnerable patients with heart failure who may potentially benefit from targeted personalized care interventions aiming to reduce readmissions.Inclusion criteria:This review considered studies including adult patients who had heart failure with a reduced left ventricular ejection fraction <= 40% who were discharged after a heart failure hospitalization. The authors included studies with experimental and observational designs evaluating risk factors for i) all-cause hospital readmission, ii) heart failure hospital readmission, and iii) composite outcomes within seven, 15, 30, 60, 90, 180, and 365 days after hospital discharge. Composite outcomes included end points where all-cause readmission and/or heart failure readmission were part of a defined end point (i.e. all-cause readmission or mortality; heart failure readmission or mortality; cardiovascular readmission; cardiovascular readmission or mortality; and readmission, mortality, or cardiac transplant). Studies reporting all-cause readmission and/or heart failure readmission as a primary outcome, secondary outcome, or part of a composite outcome were included.Methods:PubMed, Embase, CINAHL, Cochrane CENTRAL, PsycINFO, OpenGrey, MedNar, DART-Europe, ProQuest Dissertations and Theses, and the Grey Literature Report in Public Health were searched to find both published and unpublished studies in English, Swedish, Norwegian, or Danish from 2000 to June 2018. Study selection, critical appraisal, data extraction, and data synthesis followed the JBI approach for systematic reviews. Statistical pooling was not possible due to clinical and methodological heterogeneity of the studies included and the lack of risk factors reported more than once. A narrative summary of the findings was performed.Results:Fifty-two studies, including one randomized controlled trial and 51 cohort studies with a total of 128,186 participants, were included. Risk factors for readmission were reported for 30-day outcome in 16 studies, 60-day in three studies, 90-day in 15 studies, 180-day in 12 studies, and 365-day outcome in 15 studies. Based on multivariable analyses from 43 cohort studies and results from one randomized controlled trial, the authors identified several factors associated with higher risk of all-cause readmission, heart failure readmission, and composite outcomes (e.g. readmission or death) within 30, 60, 90, 180, and 365 days after discharge for a heart failure hospitalization.Conclusions:This review provides a comprehensive overview of factors associated with a clinical outcome after a heart failure hospitalization in patients with heart failure with left ventricular ejection fraction <= 40%. Owing to the heterogeneity of variables investigated and the lack of comparability of findings, the clinical impact of the identified risk factors remains uncertain. This review highlights research gaps and the need for a standardized way to define and measure all-cause readmission, heart failure readmission, and composite end points in clinical research to improve study quality and enable comparison of findings between studies.
引用
收藏
页码:1641 / 1700
页数:60
相关论文
共 101 条
  • [1] Mortality and Readmission Following Hospitalisation for Heart Failure in Australia: A Systematic Review and Meta-Analysis
    Al-Omary, Mohammed S.
    Davies, Allan J.
    Evans, Tiffany-Jane
    Bastian, Bruce
    Fletcher, Peter J.
    Attia, John
    Boyle, Andrew J.
    [J]. HEART LUNG AND CIRCULATION, 2018, 27 (08) : 917 - 927
  • [2] Albuquerque LH., 2018, HEART LUNG, P77, DOI DOI 10.1016/J.HRTLNG.2018.10.014
  • [3] Rates and Predictors of 30-Day Readmission Among Commercially Insured and Medicaid-Enrolled Patients Hospitalized With Systolic Heart Failure
    Allen, Larry A.
    Tomic, Karen E. Smoyer
    Smith, David M.
    Wilson, Kathleen L.
    Agodoa, Irene
    [J]. CIRCULATION-HEART FAILURE, 2012, 5 (06) : 672 - 679
  • [4] Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial
    Ambrosy, Andrew P.
    Khan, Hassan
    Udelson, James E.
    Mentz, Robert J.
    Chioncel, Ovidiu
    Greene, Stephen J.
    Vaduganathan, Muthiah
    Subacuis, Haris P.
    Konstam, Marvin A.
    Swedberg, Karl
    Zannad, Faiez
    Maggioni, Aldo P.
    Gheorghiade, Mihai
    Butler, Javed
    [J]. CIRCULATION-HEART FAILURE, 2016, 9 (05)
  • [5] On admission serum sodium and uric acid levels predict 30 day rehospitalization or death in patients with acute decompensated heart failure
    Amin, Ahmad
    Chitsazan, Mitra
    Shiukhi Ahmad Abad, Fatemeh
    Taghavi, Sepideh
    Naderi, Nasim
    [J]. ESC HEART FAILURE, 2017, 4 (02): : 162 - 168
  • [6] A functional variant of the neuropeptide S receptor-1 gene modulates clinical outcomes and healthcare utilization in patients with systolic heart failure: results from the Interdisciplinary Network Heart Failure (INH) Study
    Angermann, Christiane E.
    Kaspar, Mathias
    Marx, Almuth
    Kittel-Schneider, Sarah
    Menhofer, Dominik
    Stoerk, Stefan
    Ertl, Georg
    Domschke, Katharina
    Deckert, Juergen
    Reif, Andreas
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (03) : 314 - 323
  • [7] Aromataris E., 2017, Joanna Briggs Institute reviewers manual [Internet]
  • [8] Prognostic significance of the echocardiographic estimate of pulmonary hypertension and of right ventricular dysfunction in acute decompensated heart failure. A pilot study in HFrEF patients
    Badagliacca, Roberto
    Ghio, Stefano
    Correale, Michele
    Poscia, Roberto
    Camporotondo, Rita
    Ferraretti, Armando
    Papa, Silvia
    Pezzuto, Beatrice
    Petrone, Pasquale
    Torre, Roberto
    Di Biase, Matteo
    Novara, Paola
    Guida, Stefania
    Vizza, Carmine Dario
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 271 : 301 - 305
  • [9] What are the factors in risk prediction models for rehospitalisation for adults with chronic heart failure?
    Betihavas, Vasiliki
    Davidson, Patricia M.
    Newton, Phillip J.
    Frost, Steven A.
    Macdonald, Peter S.
    Stewart, Simon
    [J]. AUSTRALIAN CRITICAL CARE, 2012, 25 (01) : 31 - 40
  • [10] Beta-blocker use and outcomes among hospitalized heart failure patients
    Butler, J
    Young, JB
    Abraham, WT
    Bourge, RC
    Adams, KF
    Clare, R
    O'Connor, C
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (12) : 2462 - 2469